Northwest Biotherapeutics Market Cap

Northwest Biotherapeutics has a market cap or net worth of $378.31 million as of June 20, 2025. Its market cap has decreased by -33.65% in one year.

Market Cap

378.31M

Enterprise Value

459.18M

Revenue

1.47M

Ranking

n/a

PE Ratio

n/a

Stock Price

$0.26

Market Cap Chart

Since December 14, 2001, Northwest Biotherapeutics's market cap has increased from 10.29M to 378.31M, an increase of 3,576.79%. That is a compound annual growth rate of 16.56%.

Market Cap History

Date	Market Cap	% Change
Jun 18, 2025	392.28M	7.78%
Dec 31, 2024	363.95M	-55.71%
Dec 29, 2023	821.84M	-1.00%
Dec 30, 2022	830.10M	25.14%
Dec 31, 2021	663.34M	-47.13%
Dec 31, 2020	1.25B	870.89%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Endo, Inc.	1.60B
Elite Pharmaceuticals	827.80M
Veradigm	747.25M
Nika Pharmaceuticals	708.22M
Tian'an Technology Group	637.25M
CytoDyn	425.33M
American Oncology Network	408.69M
Glass House Brands	384.91M

Market Cap Rankings